| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HTGM | HTG MOLECULAR DIAGNOSTICS, INC | Lawson Byron | SVP/Chief Commercial Officer | Dec 09, 2022 | Option Exercise | $0.43 | 1,000 | 425 | 6,033 | Dec 13, 2022, 05:41 PM | |
| HTGM | HTG MOLECULAR DIAGNOSTICS, INC | Lawson Byron | SVP/Chief Commercial Officer | Jun 30, 2022 | Option Exercise | $1.03 | 23 | 24 | 5,033 | Jul 01, 2022, 05:42 PM | |
| HTGM | HTG MOLECULAR DIAGNOSTICS, INC | Lawson Byron | SVP/Chief Commercial Officer | Jun 10, 2022 | Option Exercise | $0.48 | 1,000 | 476 | 5,056 | Jun 15, 2022, 04:31 PM | |
| HTGM | HTG MOLECULAR DIAGNOSTICS, INC | Lawson Byron | SVP/Chief Commercial Officer | Mar 31, 2022 | Option Exercise | $1.39 | 23 | 32 | 4,056 | Apr 04, 2022, 04:30 PM | |
| HTGM | HTG MOLECULAR DIAGNOSTICS, INC | Lawson Byron | SVP/Chief Commercial Officer | Dec 31, 2021 | Option Exercise | $5.42 | 24 | 130 | 4,079 | Jan 04, 2022, 04:40 PM | |
| HTGM | HTG MOLECULAR DIAGNOSTICS, INC | Lawson Byron | SVP/Chief Commercial Officer | Dec 10, 2021 | Option Exercise | $3.56 | 896 | 3,191 | 4,103 | Dec 15, 2021, 05:06 PM | |
| HTGM | HTG MOLECULAR DIAGNOSTICS, INC | Lawson Byron | SVP/Chief Commercial Officer | Sep 30, 2021 | Option Exercise | $5.71 | 24 | 137 | 3,207 | Oct 04, 2021, 04:36 PM | |
| HTGM | HTG MOLECULAR DIAGNOSTICS, INC | Lawson Byron | SVP/Chief Commercial Officer | Jun 30, 2021 | Option Exercise | $5.81 | 24 | 139 | 3,231 | Jul 02, 2021, 07:18 PM | |
| HTGM | HTG MOLECULAR DIAGNOSTICS, INC | Lawson Byron | SVP/Chief Commercial Officer | Jun 10, 2021 | Option Exercise | $3.92 | 354 | 1,387 | 3,255 | Jun 14, 2021, 08:30 PM | |
| HTGM | HTG MOLECULAR DIAGNOSTICS, INC | Lawson Byron | SVP/Chief Commercial Officer | Mar 31, 2021 | Option Exercise | $5.47 | 28 | 153 | 2,901 | Apr 02, 2021, 05:49 PM | |
| HTGM | HTG MOLECULAR DIAGNOSTICS, INC | Lawson Byron | SVP/Chief Commercial Officer | Dec 31, 2020 | Option Exercise | $4.79 | 24 | 115 | 2,929 | Jan 04, 2021, 05:57 PM | |
| HTGM | HTG MOLECULAR DIAGNOSTICS, INC | Lawson Byron | SVP/Chief Commercial Officer | Dec 10, 2020 | Option Exercise | $4.87 | 66 | 321 | 2,953 | Dec 16, 2020, 06:13 PM | |
| HTGM | HTG MOLECULAR DIAGNOSTICS, INC | Lawson Byron | SVP/Chief Commercial Officer | Sep 30, 2020 | Option Exercise | $0.33 | 350 | 116 | 43,333 | Oct 02, 2020, 05:47 PM | |
| HTGM | HTG MOLECULAR DIAGNOSTICS, INC | Lawson Byron | SVP/Chief Commercial Officer | Jun 30, 2020 | Option Exercise | $0.72 | 350 | 252 | 43,683 | Jul 02, 2020, 05:23 PM | |
| HTGM | HTG MOLECULAR DIAGNOSTICS, INC | Lawson Byron | SVP/Chief Commercial Officer | Jun 10, 2020 | Option Exercise | $0.55 | 1,000 | 553 | 44,033 | Jun 15, 2020, 06:21 PM | |
| HTGM | HTG MOLECULAR DIAGNOSTICS, INC | Lawson Byron | SVP/Chief Commercial Officer | Mar 31, 2020 | Option Exercise | $0.33 | 416 | 137 | 43,033 | Apr 02, 2020, 04:14 PM |
Menu